WEBSITECHANGES

Website Changes

---

01/15/2026

Musella Foundation Copayment Progam now closed to new and renewal applications

---

01/13/2026

Webinar recording available!

---

01/12/2026

Penn State advances pediatric cancer research through new targeted therapy collaboration

---

01/12/2026

Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression

---

01/12/2026

FDA Adds Brain Tumor Warning to Depo-Provera Birth Control Shot

---

01/12/2026

Origins of Brain Cancer: Where IDH-Mutant Gliomas Begin

---

01/05/2026

Glioblastoma Clinical Trial: Focused Ultrasound Blood-Brain Barrier Opening is Safe, Provides Possible Survival Benefit

---

01/05/2026

Copayment assistance program is now open!

---

12/29/2025

New drug combination boosts life expectancy from grade 3 brain tumors by more than 45%

---

12/22/2025

Upcoming Webinar!

---

12/15/2025

"Drive for a Cure" Fundraiser Event in South Florida

---

12/15/2025

Attenuation of malignant phenotype of glioblastoma following a short course of the pro-oxidant combination of Resveratrol and Copper

---

12/15/2025

Imaging Biometrics and GE HealthCare expand agreement

---

12/15/2025

Adaptive radiation therapy for glioblastoma: clinical efficacy and recurrence patterns

---

12/02/2025

Imvax Announces Positive Top-line Data from Phase 2b Clinical Trial of IGV-001 in Newly Diagnosed GBM

---

12/02/2025

Imvax Announces Positive Top-line Data from Phase 2b Clinical Trial of IGV-001 in Newly Diagnosed GBM

---

12/01/2025

One of the world`s oldest blood pressure drugs may also halt aggressive brain tumor growth

---

12/01/2025

Musella Foundation 2025 Highlights

---

12/01/2025

Glioblastoma immunotherapy trial: a new breakthrough

---

11/15/2025

Bacteria Inside Brain Tumors Could Affect How They Behave

---

11/04/2025

Servier Announces Positive Findings from Longer-Term Analysis of Phase 3 INDIGO Trial Showing Continued Durable Effect of Voranigo

---

11/03/2025

Upcoming webinar!

---

11/03/2025

FLAG Therapeutics Secures Over $500,000 in Equity and Impact Funding from Venture and Mission-Driven Investors, Including Springhood Ventures, Kids Beating Cancer, The Musella Foundation, the AYJ Fund, Tough2gether Foundation and DDRFA

---

10/27/2025

Share Your Experiences With Glioblastoma (GBM)

---

10/27/2025

Sonodynamic Therapy Using 5-Aminolevulinic Acid for Malignant Gliomas: A Review

---